LIPO
PINK Lipella Pharmaceuticals, Inc.$0.0006 ↑ +0.0001 (+20.00%) Trading Up from the previous close of $0.0005, and at the day’s high of $0.0006
- YTD change
- +200.00%
- vs 20-day SMA
- +41.18%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-0.04 (-98.64%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.9% away from all-time highs of $0.6280
- LIPO is up 200% since the beginning of the year
- LIPO is up 200% over the past 12 months
- LIPO is up 200% over the past 1 month
- 0% of all LIPO investors are betting against LIPO
LIPO reads n/a: the 12-month move is -99.9%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +20.00%
- vs 8-day SMA
- +20.00%
No alerts for LIPO in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
